Ani Pharmaceuticals Inc

MetLife Investment Management, LLC ANIP

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

10,365

Value ($000)

818

Weight

0.0%

2018 Q3 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	818	0.0%	10,365	12/31/2025
2025 Q3	11/13/2025	949	0.0%	10,365	9/30/2025
2025 Q2	8/13/2025	732	0.0%	11,219	6/30/2025
2025 Q1	5/14/2025	751	0.0%	11,219	3/31/2025
2024 Q4	2/13/2025	630	0.0%	11,397	12/31/2024
2024 Q3	11/13/2024	640	0.0%	10,722	9/30/2024
2024 Q2	8/13/2024	683	0.0%	10,722	6/30/2024
2024 Q1	5/14/2024	531	0.0%	7,676	3/31/2024
2023 Q4	4/22/2024	423	0.0%	7,676	12/31/2023
2023 Q3	5/9/2024	446	0.0%	7,676	9/30/2023
2023 Q2	4/29/2024	362	0.0%	6,726	6/30/2023
2023 Q1	5/9/2024	267	0.0%	6,726	3/31/2023
2022 Q4	5/10/2024	259	0.0%	6,438	12/31/2022
2022 Q3	5/10/2024	188	0.0%	5,858	9/30/2022
2022 Q2	5/10/2024	174	0.0%	5,858	6/30/2022
2022 Q1	5/10/2024	165	0.0%	5,858	3/31/2022
2021 Q4	5/17/2024	172	0.0%	3,731	12/31/2021
2021 Q3	5/17/2024	122	0.0%	3,731	9/30/2021
2020 Q4	5/24/2024	115	0.0%	3,945	12/31/2020
2020 Q3	5/24/2024	111	0.0%	3,945	9/30/2020
2020 Q2	5/24/2024	128	0.0%	3,945	6/30/2020
2020 Q1	7/12/2023	161	0.0%	3,945	3/31/2020
2019 Q4	7/12/2023	243	0.0%	3,945	12/31/2019
2019 Q3	7/12/2023	288	0.0%	3,945	9/30/2019
2019 Q2	7/12/2023	324	0.0%	3,945	6/30/2019
2019 Q1	7/13/2023	278	0.0%	3,945	3/31/2019
2018 Q4	7/13/2023	178	0.0%	3,945	12/31/2018
2018 Q3	7/13/2023	223	0.0%	3,945	9/30/2018